selexipag: Clinical Trials

1 trial of selexipag, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1

Follow selexipag: new trials by email Literature Review of selexipag trials Research Report on selexipag

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO)
Discontinuation of parenteral prostacyclins analogues or selexipag - Pulmonary Arterial Hypertension
Not applicableNot yet recruitingUniversity of Alberta782026-10-302026-09-23

Conditions studied

Pulmonary Arterial Hypertension (1)

Sponsors

University of Alberta (1)

Countries

Canada (1)

Top investigators

Dr. Jason Weatherald, MD, MSc, FRCPC (1)